Cargando…

HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation

OBJECTIVE: HIV-1 frequently adapts in response to immune pressure from cytotoxic T-lymphocytes (CTL). Many HIV-2 infected individuals have robust capsid-specific CTL responses associated with viral control. Despite this CTL pressure, adaptive changes in this key immunogenic HIV-2 protein have not pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Silva, Thushan I., Leligdowicz, Aleksandra, Carlson, Jonathan, Garcia-Knight, Miguel, Onyango, Clayton, Miller, Nicholas, Yindom, Louis-Marie, Hué, Stephane, Jaye, Assan, Dong, Tao, Cotten, Matthew, Rowland-Jones, Sarah L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Basic Science: Concise Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895130/ https://www.ncbi.nlm.nih.gov/pubmed/29369160 http://dx.doi.org/10.1097/QAD.0000000000001753

Ejemplares similares

HIV-2 gene product-specific T cell responses and viraemia control
por: Leligdowicz, Aleksandra, et al.
Publicado: (2006)

HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form
por: de Silva, Thushan I, et al.
Publicado: (2010)

Comparison of Cytotoxic activity and Interferon-g secretion by Natural Killer Cells in HIV-1 and HIV-2 infected individuals
por: Nuvor, Samuel Victor, et al.
Publicado: (2010)

Intrahost evolution of the HIV-2 capsid correlates with progression to AIDS
por: Boswell, M T, et al.
Publicado: (2022)

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians
por: Jobarteh, Modou, et al.
Publicado: (2010)

The presence of prolines in the flanking region of an immunodominant HIV‐2 gag epitope influences the quality and quantity of the epitope generated
por: Jallow, Sabelle, et al.
Publicado: (2015)

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
por: Stewart, Balint, et al.
Publicado: (2011)

Are Plasma Biomarkers of Immune Activation Predictive of HIV Progression: A Longitudinal Comparison and Analyses in HIV-1 and HIV-2 Infections?
por: Nyamweya, Samuel, et al.
Publicado: (2012)

Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa
por: Togun, Toyin, et al.
Publicado: (2011)

Haematological measurements and iron levels in HIV-infected Gambian subjects
por: Bah, Gibril, et al.
Publicado: (2006)

Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains
por: Lucas, Julie, et al.
Publicado: (2023)

Global population-level association between herpes simplex virus 2 prevalence and HIV prevalence
por: Kouyoumjian, Silva P., et al.
Publicado: (2018)

Distinct antibody profiles in HLA-B(∗)57(+), HLA-B(∗)57(−) HIV controllers and chronic progressors
por: Klingler, Jéromine, et al.
Publicado: (2022)

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection
por: Martin, Genevieve E., et al.
Publicado: (2017)

Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV
por: Nunes, Marta C., et al.
Publicado: (2023)

The influence of constraints on the efficient allocation of resources for HIV prevention
por: Stopard, Isaac J., et al.
Publicado: (2019)

Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village
por: van der Loeff, Maarten F Schim, et al.
Publicado: (2010)

HIV-1 replicates and persists in vaginal epithelial dendritic cells
por: Pena-Cruz, Victor, et al.
Publicado: (2018)

Comparison of Biochemical Properties of HIV-1 and HIV-2 Capsid Proteins
por: Miyazaki, Yasuyuki, et al.
Publicado: (2017)

Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa
por: Okomo, Uduak, et al.
Publicado: (2012)

Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda
por: Naluyima, Prossy, et al.
Publicado: (2014)

HLA Correlates of Long-Term Survival in Vertically Infected HIV-1-Positive Adolescents in Harare, Zimbabwe
por: Shepherd, Brittany L., et al.
Publicado: (2015)

Tracking development assistance for HIV/AIDS: the international response to a global epidemic
por: Schneider, Matthew T., et al.
Publicado: (2016)

Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort
por: Zhang, Yonghong, et al.
Publicado: (2015)

Resisting Immune Exhaustion in HIV-1 Infection
por: Rowland-Jones, Sarah, et al.
Publicado: (2008)

Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma
por: Kraft, John C., et al.
Publicado: (2017)

Evaluation of geospatial methods to generate subnational HIV prevalence estimates for local level planning
Publicado: (2016)

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2021)

HIV Capsid and Integration Targeting
por: Engelman, Alan N.
Publicado: (2021)

HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007
por: van Tienen, Carla, et al.
Publicado: (2010)

Inferring population HIV incidence trends from surveillance data of recent HIV infection among HIV testing clients
por: Godin, Arnaud, et al.
Publicado: (2021)

In Vivo Functions of CPSF6 for HIV-1 as Revealed by HIV-1 Capsid Evolution in HLA-B27-Positive Subjects
por: Henning, Matthew S., et al.
Publicado: (2014)

Correction: Resisting Immune Exhaustion in HIV-1 Infection
por: Rowland-Jones, Sarah, et al.
Publicado: (2008)

HIV and urethritis: time required for antiretroviral therapy to suppress HIV in semen
por: Matoga, Mitch, et al.
Publicado: (2023)

A17 The effect of intra-host evolution of HIV-2 capsid on disease progression
por: Boswell, M T, et al.
Publicado: (2019)

Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa
por: Sanders, Eduard J., et al.
Publicado: (2017)

Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1
Publicado: (2019)

Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral rebound
por: Cale, Evan M., et al.
Publicado: (2020)

Preexisting memory CD4(+) T cells contribute to the primary response in an HIV-1 vaccine trial
por: Campion, Suzanne L., et al.
Publicado: (2021)

Diagnostic stewardship for human immunodeficiency virus (HIV) testing using computerized physician order entry
por: Wilber, Eli P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hdh6ev3kvvqk6aji6j70e6bcb6